190 related articles for article (PubMed ID: 30333087)
1. The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
Dottorini L; Catena L; Sarno I; Di Menna G; Marte A; Novelli E; Rusca C; Bajetta E
J Geriatr Oncol; 2019 Mar; 10(2):356-358. PubMed ID: 30333087
[TBL] [Abstract][Full Text] [Related]
2. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.
Cavusoglu C; Tahtaci G; Dogrul RT; Ileri I; Yildirim F; Candemir B; Kizilarslanoglu MC; Uner A; Goker B
BMC Geriatr; 2021 Oct; 21(1):574. PubMed ID: 34666690
[TBL] [Abstract][Full Text] [Related]
3. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
[TBL] [Abstract][Full Text] [Related]
4. A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.
Hentschel L; Rentsch A; Lenz F; Hornemann B; Schmitt J; Baumann M; Ehninger G; Schuler M
Oncol Res Treat; 2016; 39(4):210-6. PubMed ID: 27160741
[TBL] [Abstract][Full Text] [Related]
5. Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.
Neve M; Jameson MB; Govender S; Hartopeanu C
J Geriatr Oncol; 2016 Nov; 7(6):457-462. PubMed ID: 27313080
[TBL] [Abstract][Full Text] [Related]
6. Performance of two geriatric screening tools in older patients with cancer.
Kenis C; Decoster L; Van Puyvelde K; De Grève J; Conings G; Milisen K; Flamaing J; Lobelle JP; Wildiers H
J Clin Oncol; 2014 Jan; 32(1):19-26. PubMed ID: 24276775
[TBL] [Abstract][Full Text] [Related]
7. Screening for frailty among older patients with cancer that qualify for abdominal surgery.
Kenig J; Zychiewicz B; Olszewska U; Richter P
J Geriatr Oncol; 2015 Jan; 6(1):52-9. PubMed ID: 25277874
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors.
Ingle JN
Breast; 2013 Aug; 22 Suppl 2():S180-3. PubMed ID: 24074784
[TBL] [Abstract][Full Text] [Related]
9. The VES-13 and G-8 tools as predictors of toxicity associated with aromatase inhibitors in the adjuvant treatment of breast cancer in elderly patients: A single-center study.
Irelli A; Sirufo MM; Scipioni T; Aielli F; Martella F; Ginaldi L; Pancotti A; Martinis M
Indian J Cancer; 2022; 59(4):485-492. PubMed ID: 36861519
[TBL] [Abstract][Full Text] [Related]
10. Validation of the G8 screening tool in older patients with aggressive haematological malignancies.
Velghe A; Petrovic M; De Buyser S; Demuynck R; Noens L
Eur J Oncol Nurs; 2014 Dec; 18(6):645-8. PubMed ID: 24954768
[TBL] [Abstract][Full Text] [Related]
11. Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.
Dubruille S; Libert Y; Roos M; Vandenbossche S; Collard A; Meuleman N; Maerevoet M; Etienne AM; Reynaert C; Razavi D; Bron D
J Geriatr Oncol; 2015 Sep; 6(5):362-9. PubMed ID: 26277114
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
Chan A; De Boer R; Gan A; Willsher P; Martin R; Zissiadis Y; Miller K; Bauwens A; Hastrich D
Support Care Cancer; 2017 Dec; 25(12):3785-3791. PubMed ID: 28691132
[TBL] [Abstract][Full Text] [Related]
13. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
Ellis GK; Bone HG; Chlebowski R; Paul D; Spadafora S; Smith J; Fan M; Jun S
J Clin Oncol; 2008 Oct; 26(30):4875-82. PubMed ID: 18725648
[TBL] [Abstract][Full Text] [Related]
15. Relevance of G8 scale in referring elderly patients with aortic stenosis requiring a TAVI for a geriatric consultation.
de Thézy A; Lafargue A; d'Arailh L; Dijos M; Leroux L; Salles N; Rainfray M
Geriatr Psychol Neuropsychiatr Vieil; 2017 Dec; 15(4):357-363. PubMed ID: 29187325
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors and arthralgia: a growing pain?
Murphy C; Hudis CA; Dickler MN
Oncology (Williston Park); 2008 Nov; 22(12):1424, 1426. PubMed ID: 19322950
[No Abstract] [Full Text] [Related]
17. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.
Nyrop KA; Callahan LF; Rini C; Altpeter M; Hackney B; DePue A; Wilson A; Schechter A; Muss HB
Support Care Cancer; 2016 Jun; 24(6):2643-50. PubMed ID: 26757739
[TBL] [Abstract][Full Text] [Related]
19. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
[TBL] [Abstract][Full Text] [Related]
20. First validation of the G-8 geriatric screening tool in older patients with glioblastoma.
Deluche E; Leobon S; Lamarche F; Tubiana-Mathieu N
J Geriatr Oncol; 2019 Jan; 10(1):159-163. PubMed ID: 30037767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
